Biolinq

Biolinq is a complete rethink of the CGM form factor, using an array of electrochemical sensors so small you can barely feel them. Their array of sensors provide incredible reliability for continuous sensing applications that deliver a truly new experiences - capable of measuring glucose, as well a complete metabolic profile, in a way that opens it to incredible new opportunities.

Freenome

The first liquid biopsy company that will clear FDA approvals for cancer diagnostics, with leading sensitivity and specificity. Freenome is revolutionizing early cancer detection with its cutting-edge multiomics test, an innovative fusion of tumor and non-tumor biomarkers, synthesized through advanced machine learning algorithms

Candid Care

There’s always something captivating about an industry disruptor, a company that not only dares to challenge the status quo but does so with an impressive arsenal of innovation, market understanding, and strategic pivots. Enter Candid Care Co (Candid) — a shining example in the orthodontic realm.

Journey of a Revolution

Founded in 2017 with a vision to redefine orthodontics, Candid embarked on a journey to create a clear aligner that would pave the way for every dentist to offer innovative dental solutions. Their endeavors were backed by a whopping $300M investment, with Philips showing confidence through a $150M Series D round in 2021.

In its initial years, Candid was all about creating a cost-effective, technology-driven, and comfortable in-home treatment for patients. This direct-to-consumer approach saw them successfully treating over 10,000 patients. Through this phase, the company made vital market revelations: the importance of predictability and monitoring, patients' trust in consulting their dentists for aligner treatments and the significance of time-in-chair for dentists. With these insights, Candid shifted gears, focusing on direct sales to dentists.

What Sets Candid Apart?

Candid isn’t just another player in the market. They stand out, and here’s why:

• GTM: CandidPro is the single largest opportunity for dentists to add to their bottom line. It is a recurring revenue model that adds value to the dentist and is far more convenient for the patient.

• Strategic partnerships: Candid has strategic partnerships with three of the largest and most important players in the dental space

• Excellent management: thoughtful and introspective leadership finds opportunities and makes the right decisions when necessary

• Differentiated product: Candid’s aligners are designed for prolonged force application over extended durations, ensuring less initial discomfort and a more comfortable patient experience.

• Better outcomes: innovative design ensures better results with fewer patients requiring tooth attachments - better for patients and easier for dentists

• Smart Monitoring: Candid's home monitoring technology monitors tooth movement, identifying potential issues, and ensuring patient adherence. Fewer visits makes it easier for patients and more cost effective for dentists.

• Technological Prowess: An investment exceeding $100M in R&D has led to the creation of a compelling technology suite, further backed by Philips’s own third-party research.

Beyond Cosmetic Appeal

While many competitors zero in on aesthetics, Candid goes a step further. Their aligners not only straighten teeth but can also potentially alleviate airway-related issues like sleep apnea, snoring, and other breathing complications. With an aim to acquire FDA clearance for treating mild to moderate Obstructive Sleep Apnea (OSA), Candid stands out as a holistic orthodontic solution provider.

We couldn’t be more excited to be a part of Candid’s journey